SUMMARY Oro-facial dyskinesia and purposeless trunk and limb movements were assessed, using a standard videotape rating technique, in 182 psychiatric patients receiving antipsychotic medication, in a second sample of 43 elderly psychiatric patients also receiving antipsychotic drugs, and 85 normal, drug-naive subjects. In both the first patient sample and the group of normal subjects, oro-facial dyskinesia was more common over 50 years of age. Statistical analysis of the data suggested that drug-induced oro-facial dyskinesia has a characteristic pattern of movement distribution significantly different from that of idiopathic oro-facial dyskinesia. The videotapes of the first patient sample and the normal subjects were viewed by a neurologist who assessed and categorised all movements. Purposeless trunk and limb movements were classified as either normal or abnormal. Normal purposeless movements were significantly more common in the drug-naive subjects. The presence of abnormal movements such as choreiform movements, dystonias and stereotypies and mannerisms was limited, almost exclusively, to the patients.
Tardive dyskinesia is a movement disorder induced by antipsychotic drugs. It is characterised by abnormal movements affecting the face, principally the tongue, lips and jaw, producing a typical picture referred to as the bucco-linguo-masticatory syndrome. ' Choreiform movements of the limbs and axial hyperkinesias are usually included within the syndrome description. However, there are a number of problems inherent in trying to assess tardive dyskinesia quantitatively and qualitatively. 23 The operational diagnostic criteria used between clinical research groups vary considerably and this complicates the interpretation of results. There are also discrepancies between the rating scales used, not only regarding the number and definition of movement categories included but also their relative importance, as indicated by the scoring systems. The precise nature and distribution of abnormal movements are seldom attended to by investigators. Rather, the individual dyskinetic phenomena tend to be obscured by the use of arbitrary global categones.
Tardive dyskinesia is not specific to schizophrenic patients and has been reported in non-psychotic psychiatric populations receiving antipsychotic drugs. [4] [5] [6] [7] [8] [9] In addition, a condition described as spontaneous or idiopathic oro-facial dyskinesia has been described in psychiatric inpatients, predominantly elderly, who have apparently never received antipsychotic drugs.56 10-16 However, as Crane'7 has stated "chronicity of disease and/or institutionalisation with attendant emotional and physical deprivation", may be responsible for these abnormal movements, being a common factor in both drugtreated and non-drug-treated psychiatric inpatients. But Altrocchi'8 has described two outpatient cases presenting with idiopathic or spontaneous oro-facial dyskinesia, and this condition has been observed as a relatively rare phenomenon in normal drug-free residents in old-age homes.5 19 Marsden and Parkes20 estimated that this condition is present in some 2% of the geriatric home population. These cases are generally considered to be phenomenologically indistinguishable from tardive dyskinesia,I82021 and a similar pathophysiological basis has been suggested. 22 In this study we set out to investigate the nature and distribution of semi-purposeful and purposeless spontaneous movements in psychiatric patients treated with antipsychotic drugs, compared with those observed in a control population. 540
Method
The first group of subjects consisted of 182 psychiatric patients, all of whom had been receiving antipsychotic medication for at least one year. In addition, 85 drug-naive normal individuals were studied; compriging an unselected sample of surgical outpatients, plus hospital and medical school staff. Subsequently, six wards were chosen at random at a different mental hospital and a second patient group of 43 elderly, chronic psychiatric inpatients, was identified and examined. All had a case-note diagnosis of schizophrenia and all were receiving maintenance antipsychotic medication. Table 1 provides details of the demographic and clinical characteristics of the three samples. Informed consent was obtained from all subjects following explanation of the procedures involved.
A tardive dyskinesia rating technique, previously described by Barnes and Trauer,3 was employed. All patients were videotaped while engaged in a standard activity; seated and reading a piece of large-type prose as part of a simple comprehension test. For each subject the duration of purposeless movements at each of eight body sites was rated on a four-point scale, (0 = absent, 1 = movement present less than half the one minute observation period, 2 = movement present more than half the time but not continuously, 3 = continuous movement); the criterion of severity therefore, being the proportion of the observation period that the movement was present. All tapes were rated by three independent observers, blind to whether the subjects were patients or normal controls. For each set of three ratings a single "modal" score was derived according to a method previously described. 
Results
The mean scores for duration of movement for the first group of 182 patients and the 85 normal subjects, were plotted in five age-bands for each body site, producing the "movement profiles" displayed in Figure 1 . In order to reduce the five age-profiles to a single representative profile for each population, the movement scores were adjusted for age by analysis of covariance (see Method). Figure 2 displays the adjusted scores as both a graphical plot, to illustrate the distribution pattern and also, more appropriately, as a histogram. The analysis of covariance allowed examination of the independent contributions of (1) drug exposure (patients or normal subjects), (2) body site and (3) the interaction of (1) and (2) to the explanation of the total variance. All three sources have statistically significant category was compared in subjects above and below 50 years of age. In the sample of normal subjects there were significantly more subjects below 50 years of age with no significant movement (p < 0-01). In the patient group, choreiform movements were significantly more common in patients over 50 years of age (p < 0-02).
The presence of oro-facial dyskinesia was determined by one of the authors, (MR) for each of the 267 subjects and, as can be seen from table 3, his (see  table 3 ).
In both psychiatric patients treated with antipsychotic drugs and in drug-naive subjects, the amount of oro-facial movement observed was found to be higher in the older age groups. Twenty percent of untreated subjects over 50 years of age were considered to have oro-facial dyskinesia; a prevalence consistent with that found in surveys of larger but similar samples."4 19 25 26 However, oro-facial dyskinesia was more common in the psychiatric patients treated with antipsychotic drugs, than in drug-naive subjects. Thus age and antipsychotic drug treatment would appear to be relevant factors in the prevalence and severity of oro-facial dyskinesia; a finding that is consistent with previous reports.27-29 The number of non-schizophrenic drug-treated cases was too small for meaningful analysis, so the possibility that oro-facial dyskinesia is related to schizophrenia cannot be excluded.
The central or oro-facial movement profile in the patient sample has the same characteristic pattern in all five age-groups except the lowest (see fig 1) . This reinforces the finding by Gerlach30 that oro-facial dyskinesia increases in severity with age without any change in the topographic distribution or movement pattern. Similarly, the oro-facial profile in the normal subjects has a characteristic pattern throughout the age-groups. However, the age-adjusted central profile for patients is different from the corresponding profile for normal controls. These two characteristic patterns, derived from ratings of movement in a standard situation, as described, possibly reflect different pathophysiological mechanisms. Whether the differences between the two movement patterns are distinct enough to allow discrimination clinically between the two conditions, remains to be tested.
With regard to the trunk and limb (peripheral) movements rated, when the patterns of movement distribution for the four relevant body sites in the patient sample and normal individuals were compared, they were not different. However, these profiles reflect only the proportion of time the patients manifested purposeless movements. Attention to the nature of these movements is necessary in order to compare the patient and normal subject samples, and to estimate the clinical importance and therapeutic implications of trunk and limb movement problems related to antipsychotic drug administration. The information presented in table 2 indicates that the movements rated in the normal controls were predominantly semi-purposeful or purposeless normal movements; these were more prevalent in the subjects over 50 years of age. Apart from two elderly normal controls who manifest choreiform movements, abnormal movements occurred only in the patient sample. While choreiform movements were more common in patients over 50 years old there was no association between age and the presence of dystonic phenomena or stereotypies and mannerisms. Stereotypies and mannerisms are traditionally associated with a schizophrenic illness and their association with antipsychotic drug treatment is thus doubtful. However, for choreiform movements and dystonias, antipsychotic drug treatment would appear to be an important factor in development. In addition, age may be specifically relevant to the emergence of choreiform movements.
Choreiform movements of the trunk and limbs were seen in 24% of subjects over 50 years old in the first patient sample. According to Rosen et 
